Schopper D, Dawson A, Upshur R, Ahmad ASI, Jesani A, et al.
2015-02-26 • BMC Medical Ethics
2015-02-26 • BMC Medical Ethics
BACKGROUND Médecins Sans Frontières (MSF) is one of the world’s leading humanitarian medical organizations. The increased emphasis in MSF on research led to the creation of an ethics...
Schopper D, Ravinetto R, Schwartz L, Kamaara E, Sheel S, et al.
2016-11-01 • Public Health Ethics
2016-11-01 • Public Health Ethics
The Médecins Sans Frontières (MSF) ethics review board (ERB) has been solicited in an unprecedented way to provide advice and review research protocols in an 'emergency' mode during the ...
van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, et al.
2016-01-07 • New England Journal of Medicine
2016-01-07 • New England Journal of Medicine
BACKGROUND In the wake of the recent outbreak of Ebola virus disease (EVD) in several African countries, the World Health Organization prioritized the evaluation of treatment with co...
Sunyoto T, Potet J, den Boer ML, Ritmeijer KKD, Postigo JAR, et al.
2019-05-01 • BMJ Open
2019-05-01 • BMJ Open
OBJECTIVES:
To understand stakeholders' perceptions of the access barriers to quality-assured diagnostics and medicines for leishmaniasis in the high-burden region of eastern Africa...
Diro EGJ, Ritmeijer KKD, Boelaert M, Alves F, Mohammed R, et al.
2017-09-13 • Clinical Infectious Diseases
2017-09-13 • Clinical Infectious Diseases
We have conducted a single-arm trial evaluating monthly pentamidine secondary prophylaxis (PSP) to prevent visceral leishmaniasis (VL) relapse in Ethiopian HIV-patients. Outcomes at 12 m...
2016-11-10 • Journal of Pharmaceutical Policy and Practice
2016-11-10 • Journal of Pharmaceutical Policy and Practice
The globalization of pharmaceutical production has not been accompanied by a strengthening and harmonization of the regulatory systems worldwide. Thus, the global market is characterized...
